Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease ContinuumAndréa Lessa Benedet, Alyssa Stevensson, Natàlia Vilor‐Tejedor et al.|JAMA Neurology|2021Cited by 627
Association of Phosphorylated Tau Biomarkers With Amyloid Positron Emission Tomography vs Tau Positron Emission TomographyJoseph Therriault, Pedro Rosa‐Neto, Marie Vermeiren et al.|JAMA Neurology|2022Cited by 261
Comparing tau status determined via plasma pTau181, pTau231 and [18F]MK6240 tau-PETCécile Tissot, Pedro Rosa‐Neto, Joseph Therriault et al.|EBioMedicine|2022Cited by 76
Plasma p-tau217 and tau-PET predict future cognitive decline among cognitively unimpaired individuals: implications for clinical trialsRik Ossenkoppele, Oskar Hansson, Gemma Salvadó et al.|Nature Aging|2025Cited by 68
Cryo-EM structure of Alzheimer’s disease tau filaments with PET ligand MK-6240Peter Kunach, Sarah H. Shahmoradian, Jaime Vaquer‐Alicea et al.|Nature Communications|2024Cited by 41